217 related articles for article (PubMed ID: 36827928)
1. Kynurenine pathway metabolites modulated the comorbidity of IBD and depressive symptoms through the immune response.
Lai W; Huang Z; Li S; Li XG; Luo D
Int Immunopharmacol; 2023 Apr; 117():109840. PubMed ID: 36827928
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease.
Chen LM; Bao CH; Wu Y; Liang SH; Wang D; Wu LY; Huang Y; Liu HR; Wu HG
J Neuroinflammation; 2021 Jun; 18(1):135. PubMed ID: 34127024
[TBL] [Abstract][Full Text] [Related]
3. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.
Garrison AM; Parrott JM; Tuñon A; Delgado J; Redus L; O'Connor JC
Psychoneuroendocrinology; 2018 Aug; 94():1-10. PubMed ID: 29734055
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan Metabolism through the Kynurenine Pathway is Associated with Endoscopic Inflammation in Ulcerative Colitis.
Sofia MA; Ciorba MA; Meckel K; Lim CK; Guillemin GJ; Weber CR; Bissonnette M; Pekow JR
Inflamm Bowel Dis; 2018 Jun; 24(7):1471-1480. PubMed ID: 29796641
[TBL] [Abstract][Full Text] [Related]
5. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences.
Fujigaki H; Yamamoto Y; Saito K
Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan-kynurenine metabolic characterization in the gut and brain of depressive-like rats induced by chronic restraint stress.
Li CC; Ye F; Xu CX; Jiang N; Chang Q; Liu XM; Pan RL
J Affect Disord; 2023 May; 328():273-286. PubMed ID: 36746244
[TBL] [Abstract][Full Text] [Related]
7. An Insight into the Roles of Dietary Tryptophan and Its Metabolites in Intestinal Inflammation and Inflammatory Bowel Disease.
Li X; Zhang ZH; Zabed HM; Yun J; Zhang G; Qi X
Mol Nutr Food Res; 2021 Mar; 65(5):e2000461. PubMed ID: 33216452
[TBL] [Abstract][Full Text] [Related]
8. Alterations in Kynurenine and NAD
Wnorowski A; Wnorowska S; Kurzepa J; Parada-Turska J
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948292
[TBL] [Abstract][Full Text] [Related]
9. Moxibustion alleviates depression-like behavior in rats with Crohn's disease by inhibiting the kynurenine pathway metabolism in the gut-brain axis.
Bao C; Huang J; Wu H; Ma Y; Zhou H; Chen L; Yang D; Liu H; Shi Y; Lu Y
Front Neurosci; 2022; 16():1019590. PubMed ID: 36570839
[TBL] [Abstract][Full Text] [Related]
10. Involvement of kynurenine pathway between inflammation and glutamate in the underlying etiopathology of CUMS-induced depression mouse model.
Wu X; Chen B; Di Z; Jiang S; Xu H; Shi M; Hu R; Sun S; Song Z; Liu J; Ma R; Guo Q
BMC Neurosci; 2022 Nov; 23(1):62. PubMed ID: 36357867
[TBL] [Abstract][Full Text] [Related]
11. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
[TBL] [Abstract][Full Text] [Related]
12. Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression.
Haroon E; Welle JR; Woolwine BJ; Goldsmith DR; Baer W; Patel T; Felger JC; Miller AH
Neuropsychopharmacology; 2020 May; 45(6):998-1007. PubMed ID: 31940661
[TBL] [Abstract][Full Text] [Related]
13. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
[TBL] [Abstract][Full Text] [Related]
14. DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota.
Zhao LP; Wu J; Quan W; Zhou Y; Hong H; Niu GY; Li T; Huang SB; Qiao CM; Zhao WJ; Cui C; Shen YQ
Front Immunol; 2022; 13():1089200. PubMed ID: 36776388
[TBL] [Abstract][Full Text] [Related]
15. The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis.
Baumgartner R; Forteza MJ; Ketelhuth DFJ
Cytokine; 2019 Oct; 122():154148. PubMed ID: 28899580
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system.
Ala M
Int Rev Immunol; 2022; 41(3):326-345. PubMed ID: 34289794
[TBL] [Abstract][Full Text] [Related]
17. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
[TBL] [Abstract][Full Text] [Related]
18. The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives.
Ciapała K; Mika J; Rojewska E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681715
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease.
Boros FA; Klivényi P; Toldi J; Vécsei L
Expert Opin Ther Targets; 2019 Jan; 23(1):39-51. PubMed ID: 30449219
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in clinical trials targeting the kynurenine pathway.
Pires AS; Sundaram G; Heng B; Krishnamurthy S; Brew BJ; Guillemin GJ
Pharmacol Ther; 2022 Aug; 236():108055. PubMed ID: 34929198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
